In this research, we observed that APE/AFE treatment downregulated the PI3K level and the p-AKT/AKT ratio in the AOM/DSS-induced CAC mouse model and inhibited the expression of its downstream targets, including mTOR and PPAR-γ. The gene discussed is AKT1; the disease is infectious otitis media.